Among our cohort of adolescents and young adults with perinatally acquired human immunodeficiency virus, few (17.6%) had measles protective antibodies by plaque reduction neutralization (PRN). Agreement was demonstrated between the commercial enzyme immunoassay and the PRN assay (K = 0.59 [95% confidence interval: 0.23-0.95]). Further studies are needed to understand the determinants of immunity in this population.
|Original language||English (US)|
|Number of pages||4|
|Journal||Journal of the Pediatric Infectious Diseases Society|
|State||Published - Mar 1 2015|
- Measles immunity
- Perinatally acquired HIV infection
ASJC Scopus subject areas